Israel - English - Ministry of Health

genmedix , israel - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - oxaliplatin - oxaliplatin in combination with 5 fluorouracil (5 fu) and folinic acid (fa) is indicated for: • adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumour. • treatment of metastatic colorectal cancer. oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).

Israel - English - Ministry of Health

genmedix , israel - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - oxaliplatin - oxaliplatin in combination with 5 fluorouracil (5 fu) and folinic acid (fa) is indicated for: • adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumour. • treatment of metastatic colorectal cancer. oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - oxaliplatin 5 mg/ml;  ;  ; oxaliplatin 5 mg/ml - concentrate for infusion - 5 mg/ml - active: oxaliplatin 5 mg/ml     excipient: lactose monohydrate water for injection active: oxaliplatin 5 mg/ml excipient: nitrogen water for injection - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - oxaliplatin 100mg - powder for infusion - 100 mg - active: oxaliplatin 100mg excipient: lactose monohydrate nitrogen water for injection - oxaliplatin, in combination with 5-fluorouracil and folinic acid, is indicated for adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - oxaliplatin 50mg;   - powder for infusion - 50 mg - active: oxaliplatin 50mg   excipient: lactose monohydrate nitrogen water for injection - oxaliplatin, in combination with 5-fluorouracil and folinic acid, is indicated for adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour.

Malta - English - Medicines Authority

accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - oxaliplatin, quantity: 100 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; treatment of advanced colorectal cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - oxaliplatin, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; treatment of advanced colorectal cancer.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxaliplatin 100mg;   - powder for injection - 100 mg - active: oxaliplatin 100mg   excipient: lactose

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxaliplatin 50mg;   - powder for injection - 50 mg - active: oxaliplatin 50mg   excipient: lactose